INmune Bio, Inc. (INMB)
NASDAQ: INMB · IEX Real-Time Price · USD
8.07
-0.35 (-4.16%)
Jul 2, 2024, 4:00 PM EDT - Market closed
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $159.64 million as of July 2, 2024. Its market cap has increased by 5.79% in one year.
Market Cap
159.64M
Enterprise Value
141.58M
1-Year Change
5.79%
Ranking
Category
Stock Price
$8.07
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has increased from $77.70M to $159.64M, an increase of 105.46%. That is a compound annual growth rate of 14.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 159.60M | -21.34% |
| Dec 29, 2023 | 202.90M | 78.30% |
| Dec 30, 2022 | 113.80M | -37.47% |
| Dec 31, 2021 | 182.00M | -21.42% |
| Dec 31, 2020 | 231.60M | 270.56% |
| Dec 31, 2019 | 62.50M | -19.56% |
| Feb 4, 2019 | 77.70M | - |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| High Tide | 177.78M |
| 908 Devices | 177.60M |
| Butterfly Network | 177.16M |
| Alpha Tau Medical | 176.59M |
| Biodesix | 175.47M |
| Abeona Therapeutics | 173.68M |
| Outlook Therapeutics | 172.73M |
| Fennec Pharmaceuticals | 166.94M |